Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1982 Mar;45(3):429–437. doi: 10.1038/bjc.1982.71

In vivo tumour-cell proliferation after adriamycin treatment.

R Rowley, H A Hopkins, W B Looney
PMCID: PMC2010913  PMID: 7073936

Abstract

Adriamycin (10 mg/kg) administered s.c. to male ACI rats bearing Hepatoma H-4-II-E caused a 9-day delay in tumour growth but no changes in the clonogenic fraction of the tumour were detectable by in vitro assay at any time after treatment. There is no significant decrease in the yield of cells on enzymatic dissociation of the tumour nor a reduction in mg DNA/g tumour that might indicate a decrease in tumour cellularity. Mitotic and labelling indices and [3H]dT uptake into DNA remain essentially unchanged, relative to age-equivalent controls, but are slightly lower than in controls of equal weight. The reliability of the clonogenic assay and possible mechanisms by which Adriamycin delays tumour growth are discussed.

Full text

PDF
429

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BURTON K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J. 1956 Feb;62(2):315–323. doi: 10.1042/bj0620315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Braunschweiger P. G., Schiffer L. M. Effect of adriamycin on the cell kinetics of 13762 rat mammary tumors and implications for therapy. Cancer Treat Rep. 1980 Feb-Mar;64(2-3):293–300. [PubMed] [Google Scholar]
  3. Byfield J. E., Lee Y. C., Tu L. Molecular interactions between adriamycin and x-ray damage in mammalian tumor cells. Int J Cancer. 1977 Feb 15;19(2):186–193. doi: 10.1002/ijc.2910190208. [DOI] [PubMed] [Google Scholar]
  4. CALENDI E., DIMARCO A., REGGIANI M., SCARPINATO B., VALENTINI L. ON PHYSICO-CHEMICAL INTERACTIONS BETWEEN DAUNOMYCIN AND NUCLEIC ACIDS. Biochim Biophys Acta. 1965 May 11;103:25–49. doi: 10.1016/0005-2787(65)90539-3. [DOI] [PubMed] [Google Scholar]
  5. Clarkson J. M., Humphrey R. M. The effect of adriamycin on cell cycle progression and DNA replication in chinese hamster ovary cells. Cancer Res. 1977 Jan;37(1):200–205. [PubMed] [Google Scholar]
  6. Dethlefsen L. A., Riley R. M., Roti Roti J. L. Flow cytometric analysis of adriamycin-perturbed mouse mammary tumors. J Histochem Cytochem. 1979 Jan;27(1):463–469. doi: 10.1177/27.1.374611. [DOI] [PubMed] [Google Scholar]
  7. Evans M. J., Kovacs C. J. Properties of the H-4-II-E tumor cell system. I. Growth and cell proliferation kinetics of an experimental hepatoma. Cell Tissue Kinet. 1977 May;10(3):233–243. [PubMed] [Google Scholar]
  8. Grdina D. J., Sigdestad C. P., Jovonovich J. A. Cytotoxic effect of adriamycin in vivo on synchronized murine fibrosarcoma cells. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1305–1308. doi: 10.1016/0360-3016(79)90659-x. [DOI] [PubMed] [Google Scholar]
  9. Göhde W., Meistrich M., Meyn R., Schumann J., Johnston D., Barlogie B. Cell-cycle phase-dependence of drug-induced cycle progression delay. J Histochem Cytochem. 1979 Jan;27(1):470–473. doi: 10.1177/27.1.374612. [DOI] [PubMed] [Google Scholar]
  10. Hopkins H. A., Looney W. B., Teja K., Hobson A. S., MacLeod M. S. Response kinetics of host and experimental solid tumour after adriamycin. Br J Cancer. 1978 Jun;37(6):1006–1014. doi: 10.1038/bjc.1978.146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kim S. H., Kim J. H. Lethal effect of adriamycin on the division cycle of HeLa cells. Cancer Res. 1972 Feb;32(2):323–325. [PubMed] [Google Scholar]
  12. Kimler B. F., Leeper D. B. The effect of adriamycin and radiation on G2 progression. Cancer Res. 1976 Sep;36(9 PT1):3212–3216. [PubMed] [Google Scholar]
  13. Kovacs C. J., Evans M. J., Hopkins H. A. Properties of the H-4-II-E tumor cell system. II. In vitro characteristics of an experimental tumor cell line. Cell Tissue Kinet. 1977 May;10(3):245–254. doi: 10.1111/j.1365-2184.1977.tb00292.x. [DOI] [PubMed] [Google Scholar]
  14. Martin W. M., McNally N. J. The cytotoxic action of adriamycin and cyclophosphamide on tumor cells in vitro and in vivo. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1309–1312. doi: 10.1016/0360-3016(79)90660-6. [DOI] [PubMed] [Google Scholar]
  15. Rowley R., Bacharach M., Hopkins H. A., MacLeod M., Ritenour R., Moore J. V., Looney W. B. Adriamycin and X-radiation effects upon an experimental solid tumor resistant to therapy. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1291–1295. doi: 10.1016/0360-3016(79)90656-4. [DOI] [PubMed] [Google Scholar]
  16. Rowley R., Hopkins H. A., Betsill W. L., Jr, Ritenour E. R., Looney W. B. Response and recovery kinetics of a solid tumour after irradiation. Br J Cancer. 1980 Oct;42(4):586–595. doi: 10.1038/bjc.1980.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Siemann D. W., Sutherland R. M. A comparison of the pharmacokinetics of multiple and single dose administrations of adriamycin. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1271–1274. doi: 10.1016/0360-3016(79)90652-7. [DOI] [PubMed] [Google Scholar]
  18. Siemann D. W., Sutherland R. M. In vivo tumor response to single and multiple exposures of adriamycin. Eur J Cancer. 1980 Nov;16(11):1433–1440. doi: 10.1016/0014-2964(80)90052-3. [DOI] [PubMed] [Google Scholar]
  19. Twentyman P. R., Bleehen N. M. The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour. Br J Cancer. 1976 Mar;33(3):320–328. doi: 10.1038/bjc.1976.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wang J. J., Chervinsky D. S., Rosen J. M. Comparative biochemical studies of adriamycin and daunomycin in leukemic cells. Cancer Res. 1972 Mar;32(3):511–515. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES